NPPA fixes retail prices of 80 formulations, Details
New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India has fixed retail prices of 80 formulations under Drugs (Prices Control) Order, 2013.
The authority has fixed the retail prices based on the decision of 131th Authority meeting dated 25.03.2025
The list of formulations includes Pure and Cure Healthcare/ Micro Lab's Aspirin Gastro-resistant and Rosuvastatin Capsules, Pure and Cure Healthcare/Torrent Pharmaceutical's Atorvastatin and Clopidogrel Tablets, Micro Lab's Atorvastatin and Ezetimibe Tablets, Mascot Health/Micro Lab's Atorvastatin and Ezetimibe, BRD Medilabs (Unit-II)/Troikaa Pharmaceutical's Atorvastatin Calcium and Fenofibrate Tablets.
The list also includes Ravenbhel Healthcare/ Cadila Pharmaceutical's Bisoprolol Fumarate and Telmisartan Tablets, Ravenbhel Healthcare/ Cadila Pharmaceuticals Bisoprolol Fumarate and Telmisartan Tablets.
This came in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), has fixed, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1 | Aspirin Gastro- resistant & Rosuvastatin Capsules | Each hard gelatin capsule contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg (as film coated Rosuvastatin tablets IP) Aspirin IP 75mg (as Aspirin Gastro-Resistant tablets IP) | 1 Capsule | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Micro Labs Ltd. | 10.73 |
2 | Atorvastatin & Clopidogrel Tablets | Each uncoated bilayered tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 10 mg Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Torrent Pharmaceuticals Ltd. | 14.02 |
3 | Atorvastatin & Clopidogrel Tablets | Each uncoated bilayered tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 20 mg Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Torrent Pharmaceuticals Ltd. | 18.76 |
4 | Atorvastatin & Clopidogrel Tablets | Each uncoated bilayered tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 40 mg Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Torrent Pharmaceuticals Ltd. | 25.61 |
5 | Atorvastatin & Clopidogrel Tablets | Each uncoated bilayered tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 40 mg Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Micro Labs Ltd. | 25.61 |
6 | Atorvastatin & Ezetimibe Tablets | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 10 mg Ezetimibe IP 10 mg | 1 Tablet | M/s Micro Labs Ltd. | 19.40 |
7 | Atorvastatin & Ezetimibe Tablets | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 20 mg Ezetimibe IP 10 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s Micro Labs Ltd. | 27.68 |
8 | Atorvastatin & Ezetimibe Tablets | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 40 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s Micro Labs Ltd. | 30.47 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Ezetimibe IP 10 mg | |||||
9 | Atorvastatin Calcium & Fenofibrate Tablets | Each film coated tablet contains: Atorvastatin Calcium IP eq to Atorvastatin 10 mg Fenofibrate IP 160 mg | 1 Tablet | M/s BRD Medilabs (Unit-II)/ M/s Troikaa Pharmaceuticals Ltd. | 15.91 |
10 | Bisoprolol Fumarate & Telmisartan Tablets | Each film coated tablet contains: Bisoprolol Fumarate IP 2.5 mg Telmisartan IP 40 mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd./ M/s Cadila Pharmaceuticals Ltd. | 10.28 |
11 | Bisoprolol Fumarate & Telmisartan Tablets | Each film coated tablet contains: Bisoprolol Fumarate IP 5 mg Telmisartan IP 40 mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd./ M/s Cadila Pharmaceuticals Ltd. | 11.92 |
12 | Calcium Citrate, Vitamin D3, Methylcobalamin, Pyridoxine HCl & Folic Acid Tablets | Each film coated tablet contains: Calcium Citrate USP 1000 mg Vitamin D3 IP 200 IU Methylcobalamin IP 500 mcg Pyridoxine HCl IP 10 mg Folic Acid IP 5 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s Mankind Pharma Ltd. | 14.69 |
13 | Ceftriaxone, Disodium Edetate & Sodium powder for solution for infusion | Each vial contains: Ceftriaxone Sodium IP eq. to Ceftriaxone 2000 mg Disodium Edetate IP 74 mg Sulbactam Sodium IP eq. to Sulbactam 1000 mg | 1 Vial | M/s BDR Pharmaceuticals International Pvt. Ltd./ M/s Aristo Pharmaceuticals Pvt. Ltd. | 1036.60 |
14 | Ceftriaxone, Disodium Edetate & Sodium powder for solution for infusion | Each vial contains: Ceftriaxone Sodium IP eq. to Ceftriaxone 1000 mg Disodium Edetate IP 37 mg Sulbactam Sodium IP eq. to Sulbactam 500 mg | 1 Vial | M/s BDR Pharmaceuticals International Pvt. Ltd./ M/s Aristo Pharmaceuticals Pvt. Ltd. | 515.57 |
15 | Dapagliflozin, Glimepiride & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg Glimepiride IP 1 mg Metformin Hydrochloride IP 1000 mg (as extended release) | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s USV Ltd. | 11.95 |
16 | Dapagliflozin, Glimepiride & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 1000 mg (as extended release) | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s USV Ltd. | 12.74 |
17 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 1000 mg (as Extended Release) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Cipla Ltd. | 11.83 |
18 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 1000 mg (as Extended Release) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Cadila Pharmaceuticals Ltd. | 11.83 |
19 | Empagliflozin & Metformin Hydrochloride (ER) | Each film coated bilayered tablet contains: Empagliflozin 12.5 mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Cipla Ltd. | 19.01 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Tablets | Metformin Hydrochloride IP 1000 mg (as Extended Release) | ||||
20 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated Bilayered tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg (as extended release) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Micro Labs Ltd. | 19.01 |
21 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg (as Extended Release) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Torrent Pharmaceuticals Ltd. | 19.01 |
22 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg (as Extended Release) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Aristo Pharmaceuticals Pvt. Ltd. | 19.01 |
23 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg (as Extended Release) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Cadila Pharmaceuticals Ltd. | 19.01 |
24 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Torrent Pharmaceuticals Ltd. | 15.84 |
25 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s Jagsonpal Pharmaceuticals Ltd. | 11.38 |
26 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Torrent Pharmaceuticals Ltd. | 11.38 |
27 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Aristo Pharmaceuticals Pvt. Ltd. | 18.10 |
28 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin IH 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Hetero Labs Ltd./ M/s Glenmark Pharmaceuticals Ltd. | 18.10 |
29 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Torrent Pharmaceuticals Ltd. | 18.10 |
30 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Torrent Pharmaceuticals Ltd. | 19.01 |
31 | Fexofenadine Hydrochloride & Montelukast Tablets | Each film coated tablet contains: Fexofenadine Hydrochloride IP 120 mg Montelukast Sodium IP eq. to Montelukast 10 mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd. | 14.73 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
32 | Glimepiride & Metformin Hydrochloride (SR) mg Tablets | Each uncoated bilayered tablet contains: Glimepiride IP 2 mg Metformin Hydrochloride IP (As sustained release form) 1000 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd. | 11.58 |
33 | Linagliptin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Linagliptin 2.5 mg Metformin hydrochloride IP 500 mg | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. /M/s Cadila Pharmaceuticals Ltd. | 8.12 |
34 | Magaldrate, Dicyclomine Hydrochloride, Activated Dimethicone & Oxetacaine Suspension | Each 5 ml contains: Magaldrate IP 480 mg Dicyclomine Hydrochloride IP 10 mg Activated Dimethicone IP 50 mg Oxetacaine IP 10 mg | 1 ML | M/s Indoco Remedies Ltd. | 0.53 |
35 | Pantoprazole & Levosulpiride Capsules | Each hard gelatin capsule contains: Pantoprazole Sodium IP eq. to Pantoprazole 40 mg (as gastro- resistant tablet) Levosulpiride 75 mg (as uncoated sustained release tablet) | 1 Capsule | M/s Akums Drugs & Pharmaceuticals Limited/ M/s Dr. Reddy's Laboratories Ltd. | 17.89 |
36 | Polmacoxib & Paracetamol Tablets | Each uncoated tablet contains: Polmacoxib IH 2mg Paracetamol IP 325mg | 1 Tablet | M/s Hetero Labs Limited / M/s Hetero Healthcare Ltd. | 14.75 |
37 | Povidone-Iodine Gargle | Povidone-Iodine IP 2% w/v (Available Iodine 0.2% w/v) Absolute Alcohol content 8.38% v/v | 1 ML | M/s Nanz Med Science Pharma Pvt. Ltd. /M/s Troikaa Pharmaceuticals Ltd. | 1.96 |
38 | Telmisartan & Amlodipine Tablets | Each uncoated bilayered tablet contains: Telmisartan IP 80 mg, Amlodipine Besilate IP eq. to Amlodipine 5 mg | 1 Tablet | M/s Windlas Biotech Ltd./ M/s Alkem Laboratories Ltd. | 20.15 |
39 | Mycophenolate Mofetil Oral Suspension | Each 5 ml reconstituted suspension contains: Mycophenolate Mofetil IP 1 gm | Pack of 55gm | M/s Zydus Lifesciences Ltd. | 2673.00 |
40 | Acetylcysteine & Acebrophylline Tablets | Each film coated tablet contains: Acetylcysteine BP 600 mg Acebrophylline 100 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Neon Laboratories Ltd. | 15.09 |
41 | Chlorhexidine Gluconate, Metronidazole & Lignocaine Hydrochloride Gel | Composition: Chlorhexidine gluconate solution IP eq. to Chlorhexidine 1 % w/w Metronidazole Benzoate IP eq. to Metronidazole 1 % w/w Lignocaine Hydrochloride IP 2 % w/w | 1 GM | M/s Stedman Pharmaceuticals Pvt. Ltd. | 3.65 |
42 | Sodium Alginate, Sodium Bicarbonate & Calcium carbonate Oral Liquid | Each 5 ml contains: Sodium Alginate IP 250 mg, Sodium Bicarbonate IP 133.5 mg, Calcium carbonate IP 80 mg | 1 ML | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Aurobindo Pharma Ltd. | 0.88 |
43 | Dapagliflozin & Metoprolol (ER) Tablets | Each film coated bilayer tablet contains: Dapagliflozin propanediol USP eq. to Dapagliflozin 10mg Metoprolol Succinate IP 23.75 mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Ajanta Pharma Ltd. | 15.83 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
eq. to Metoprolol Tartrate 25 mg (extended release) | |||||
44 | Dapagliflozin & Metoprolol (ER) Tablets | Each film coated bilayer tablet contains: Dapagliflozin propanediol USP eq. to Dapagliflozin 10mg Metoprolol Succinate IP 23.75 mg eq. to Metoprolol Tartrate 25 mg (extended release) | 1 Tablet | M/s Exemed Pharmaceuticals /M/s Cipla Ltd. | 15.96 |
45 | Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine Tablets | Each film coated tablet contains: Paracetamol IP 500 mg, Phenylephrine ydrochloride IP 5 mg Caffeine (Anhydrous) IP 30 mg Diphenhydramine Hydrochloride IP 25 mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s Quality Bestochem Formulations (P) Ltd. | 4.22 |
46 | Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine Tablets | Each film coated tablet contains: Paracetamol IP 500 mg, Phenylephrine Hydrochloride IP 5 mg Caffeine (Anhydrous) IP 30 mg Diphenhydramine Hydrochloride IP 25 mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s Albert David Ltd. | 4.22 |
47 | Potassium Citrate, Magnesium Citrate & Vitamin B6 Oral Solution | Each 5 ml Contains: Potassium Citrate IP 1100 mg Magnesium Citrate USP 375 mg Pyridoxine Hydrochloride (Vit.B6) IP 20 mg | 1 ML | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 0.89 |
48 | Sitagliptin, Dapagliflozin & Metformin Hydrochloride (Extended Release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500 Mg (as Extended release) | 1 Tablet | M/s Synokem Pharmaceuticals Ltd./ M/s Blue Cross Laboratories Pvt. Ltd. | 11.70 |
49 | Sitagliptin, Dapagliflozin & Metformin Hydrochloride (Extended Release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000 Mg (as Extended release) | 1 Tablet | M/s Synokem Pharmaceuticals Ltd./ M/s Blue Cross Laboratories Pvt. Ltd. | 12.60 |
50 | Telmisartan, Chlorthalidone & Metoprolol Succinate (ER) Tablets | Each film coated bilayer tablet contains: Telmisartan IP 40 mg Chlorthalidone IP 12.5 mg Metoprolol Succinate IP 47.5 mg eq. to Metoprolol Tartrate 50 mg (as extended release form) | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s Alembic Pharmaceuticals Ltd | 13.70 |
51 | Telmisartan, Chlorthalidone & Metoprolol Succinate (ER) Tablets | Each film coated bilayer tablet contains: Telmisartan IP 40 mg Chlorthalidone IP 6.25 mg Metoprolol Succinate IP 23.75 mg eq. to Metoprolol Tartrate 25 mg (as extended release form) | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s Alembic Pharmaceuticals Ltd | 10.52 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
52 | Telmisartan, Chlorthalidone & Metoprolol Succinate (ER) Tablets | Each film coated bilayer tablet contains: Telmisartan IP 40 mg Chlorthalidone IP 6.25 mg Metoprolol Succinate IP 47.5 mg eq. to Metoprolol Tartrate 50 mg (as extended release form) | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s Alembic Pharmaceuticals Ltd | 10.73 |
53 | Telmisartan, Chlorthalidone & Metoprolol Succinate (ER) Tablets | Each film coated bilayer tablet contains: Telmisartan IP 40 mg Chlorthalidone IP12.5 mg Metoprolol Succinate IP 23.75 mg eq. to Metoprolol Tartrate 25 mg (as extended release form) | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s Alembic Pharmaceuticals Ltd | 11.30 |
54 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s Glensmith Labs Pvt. Ltd. | 15.84 |
55 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 1000 mg (as Extended Release) | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Eris Lifesciences Ltd. | 11.83 |
56 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s Glensmith Labs Pvt. Ltd. | 11.38 |
57 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Lifecare Formulations Pvt. Ltd./ M/s Primus Remedies Pvt. Ltd. | 18.10 |
58 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s Glensmith Labs Pvt. Ltd. | 18.10 |
59 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Lupin Ltd. | 18.10 |
60 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s Jagsonpal Pharmaceuticals Ltd. | 18.10 |
61 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg (as Extended Release) | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Eris Lifesciences Ltd. | 19.01 |
62 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Lifecare Formulations Pvt. Ltd./ M/s Primus Remedies Pvt. Ltd. | 19.01 |
63 | Empagliflozin & Metformin | Each film coated tablet contains: Empagliflozin 12.5 mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. | 19.01 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Hydrochloride Tablets | Metformin Hydrochloride IP 1000 mg | Ltd./ M/s Jagsonpal Pharmaceuticals Ltd. | |||
64 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s Glensmith Labs Pvt. Ltd. | 19.01 |
65 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Lupin Ltd. | 19.01 |
66 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 25 mg Metformin Hydrochloride IP 1000 mg (as extended release) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Intas Pharmaceuticals Ltd. | 15.00 |
67 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 25 mg Metformin Hydrochloride IP 1000 mg (as extended release) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Eris Lifesciences Ltd. | 27.11 |
68 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 25 mg Metformin Hydrochloride IP 1000 mg (as Extended Release) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Torrent Pharmaceuticals Ltd. | 27.00 |
69 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 25 mg Metformin Hydrochloride IP 1000 mg (as Extended Release) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Aristo Pharmaceuticals Pvt. Ltd. | 27.11 |
70 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 25 mg Metformin Hydrochloride IP 1000 mg (as Extended Release) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Cipla Ltd. | 27.11 |
71 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 25 mg Metformin Hydrochloride IP 1000 mg (as Extended Release) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Cadila Pharmaceuticals Ltd. | 27.11 |
72 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 25 mg Metformin Hydrochloride IP 1000 mg (Extended Release form) | 1 Tablet | M/s Zydus Healthcare Ltd. | 27.11 |
73 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 25 mg Metformin Hydrochloride IP 1000 mg (Extended Release form) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Alkem Laboratories Ltd. | 27.11 |
74 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 10 mg Metformin Hydrochloride IP 1000 mg (as Extended Release) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Cipla Ltd. | 18.00 |
75 | Empagliflozin & | Each film coated bilayered tablet | 1 Tablet | M/s Pure & Cure | 22.96 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Metformin Hydrochloride (ER) Tablets | contains: Empagliflozin 10 mg Metformin Hydrochloride IP 1000 mg (as Extended Release) | Healthcare Pvt. Ltd./ M/s Cadila Pharmaceuticals Ltd. | |||
76 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 10 mg Metformin Hydrochloride IP 1000 mg (as Extended Release) | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Eris Lifesciences Ltd. | 22.96 |
77 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 10 mg Metformin Hydrochloride IP 1000 mg (Extended Release form) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Alkem Laboratories Ltd. | 21.43 |
78 | Dapagliflozin, Gliclazide & Metformin Hydrochloride sustained release) Tablets | Each Film Coated Bilayered Tablet contains: Dapagliflozin propanediol USP eq. to Dapagliflozin 10mg Gliclazide IP 30 mg (as sustained release form) Metformin hydrochloride IP 500mg (as Sustained release form) | 1 Tablet | M/s Eris Lifesciences Ltd. | 16.59 |
79 | Dapagliflozin, Gliclazide & Metformin Hydrochloride sustained release) Tablets | Each Film Coated Bilayered Tablet contains: Dapagliflozin propanediol USP eq. to Dapagliflozin 10mg Gliclazide IP 60 mg (as sustained release form) Metformin hydrochloride IP 500mg (as Sustained release form) | 1 Tablet | M/s Eris Lifesciences Ltd. | 20.03 |
80 | Bilastine & Montelukast Oral Suspension | Each 5ml contains: Bilastine 10mg Montelukast Sodium IP eq. to Montelukast 4mg | 1 ML | M/s Mascot Health Series Pvt. Ltd. / M/s Biological E. Limited | 1.72 |
The notification further added:
- The manufacturer of above-mentioned formulations i.e., “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
- The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
- The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
- As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
- The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
- In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
- Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2),(3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.
To view the official notice, click the link below:
Also Read:AstraZeneca Gets CDSCO Panel Nod To study Tezepelumab
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.